http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016030429-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7627b7cd00847df4c56f263404d65716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3751495573aeaa2e7748336908cdb0f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
filingDate | 2015-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8937fb31b9917555726442f27c602c51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667ed2ace8a14897e87251cac2a56197 |
publicationDate | 2016-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2016030429-A1 |
titleOfInvention | Composition and method for treating or preventing skeletal muscle fibrosis |
abstract | A compound in combination with a pharmaceutically acceptable carrier, the compound having a formula: wherein: R 1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy; R 2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy; and R 3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl; and n is either 1 or 2; and pharmaceutically acceptable salts thereof; for use in treatment of or prevention of skeletal muscle fibrosis and/or for inducing skeletal muscle regeneration. |
priorityDate | 2007-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 340.